Pierconti, Francesco
 Distribuzione geografica
Continente #
EU - Europa 3.076
NA - Nord America 2.840
AS - Asia 923
AF - Africa 23
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 6.890
Nazione #
US - Stati Uniti d'America 2.819
IT - Italia 905
SE - Svezia 626
DE - Germania 531
CN - Cina 398
SG - Singapore 280
PL - Polonia 279
UA - Ucraina 169
IE - Irlanda 143
FR - Francia 124
ID - Indonesia 102
GB - Regno Unito 76
RU - Federazione Russa 69
FI - Finlandia 54
IN - India 54
TR - Turchia 46
BE - Belgio 31
CA - Canada 19
CI - Costa d'Avorio 16
NL - Olanda 16
IR - Iran 14
CH - Svizzera 11
ES - Italia 10
JP - Giappone 7
VN - Vietnam 7
AT - Austria 6
AR - Argentina 5
AU - Australia 5
BR - Brasile 5
HK - Hong Kong 5
MA - Marocco 5
KR - Corea 4
NO - Norvegia 4
RO - Romania 4
EU - Europa 3
LT - Lituania 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
HR - Croazia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PK - Pakistan 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 6.890
Città #
Chandler 570
Warsaw 266
Ashburn 243
Singapore 223
Dublin 142
Ann Arbor 127
Milan 126
Fairfield 117
San Mateo 111
Rome 110
Jacksonville 104
Wilmington 104
Jakarta 100
Nanjing 94
Seattle 83
New York 78
Houston 68
Woodbridge 66
Dearborn 59
Moscow 56
Princeton 52
Beijing 48
Boston 47
Chicago 46
Redmond 43
Izmir 41
Bremen 40
Los Angeles 36
Marseille 34
Nanchang 34
Cattolica 31
Lawrence 28
Munich 28
Brussels 27
Cambridge 26
Nürnberg 24
Verona 24
Redwood City 21
Enterprise 18
Mountain View 18
Florence 17
Helsinki 17
Kunming 17
Naples 17
Shenyang 17
Abidjan 16
Bari 16
Bologna 16
Hangzhou 16
Tianjin 14
Falls Church 13
Hebei 13
Boardman 12
Jiaxing 12
Kraków 12
Shanghai 12
Genoa 11
Palermo 11
Augusta 9
Guangzhou 9
Miami 9
Santa Clara 8
Turin 8
Edinburgh 7
Fremont 7
Lancaster 7
London 7
Norwalk 7
Pune 7
Toronto 7
Amsterdam 6
Andover 6
Berlin 6
Casignana 6
Catania 6
Changsha 6
Jinan 6
Kish 6
Orange 6
University Park 6
Washington 6
Changchun 5
Dong Ket 5
Gonzalez Catan 5
Gunzenhausen 5
Montesilvano Marina 5
Mumbai 5
Ottawa 5
Oujda 5
Richmond 5
Vienna 5
Zurich 5
Alba 4
Ardabil 4
Ferrara 4
Hong Kong 4
Hounslow 4
Madrid 4
Messina 4
Montanaso Lombardo 4
Totale 4.017
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 731
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 331
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 206
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 200
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 177
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 168
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 147
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 144
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 125
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 124
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 119
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 117
Metabolic reprogramming by malat1 depletion in prostate cancer 112
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 109
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 109
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 108
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 104
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 102
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 100
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 88
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 85
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 84
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 84
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 82
Bladder and prostate metastasis from small cell lung cancer: a rare entity 82
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 76
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 76
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 76
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 76
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 72
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 71
Olfactory receptors in semen and in the male tract: From proteome to proteins 71
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 71
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 69
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 69
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 68
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 67
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 64
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 63
Giant spermatic cord liposarcoma 62
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 62
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 60
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 60
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 59
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 59
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 58
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 58
Proteomics for the identification of biomarkers in testicular cancer–review 57
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 56
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 55
Methylation study of the Paris system for reporting urinary (TPS) categories 55
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 54
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 54
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 54
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 54
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 53
Biomarkers of response to advanced prostate cancer therapy 52
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 51
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 51
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 50
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 50
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 50
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 49
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 48
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 47
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 47
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 46
Mesenchymal differentiation of glioblastoma stem cells 45
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 38
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 36
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 33
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 32
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 32
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 31
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 30
Mesenchymal differentiation of glioblastoma stem cells 29
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 28
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 27
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 25
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 25
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 23
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 21
p53 expression in cytology samples may represent a marker of early-stage cancer 21
Extremely delayed falx metastasis from renal cell carcinoma 21
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 21
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 19
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 19
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 19
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 19
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 15
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 14
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 14
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 12
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 12
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 11
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 10
Metastasis to the renal hilum from malignant melanoma of the anterior trunk: An unusual finding 10
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 9
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 8
First-line ICIs in renal cell carcinoma 7
Totale 7.054
Categoria #
all - tutte 31.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020518 0 0 0 0 45 63 80 36 67 32 129 66
2020/2021760 85 113 56 56 80 58 47 13 68 43 123 18
2021/2022860 76 39 27 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/20241.194 79 227 62 75 89 158 93 61 24 84 104 138
2024/2025565 70 61 196 94 144 0 0 0 0 0 0 0
Totale 7.060